Intuniv (in-TOO-niv), a new extended-release guanfacine for ADHD

November 2009

Reps will promote Intuniv (in-TOO-niv), a new extended-release guanfacine for ADHD.

It'll be used as an alternative or add-on to stimulants.

Guanfacine is an alpha-2 agonist that's been used off-label for years for ADHD...but it's dosed up to 3 times a day.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Gastroenterology help adjusting meds after bariatric surgery
Diabetes new warnings about reports of acute pancreatitis with sitagliptin (Januvia, Janumet)
two new compounding kits to make "magic mouthwash"
Influenza Compounding Tamiflu suspension and Relenza is leading to problems
Influenza giving acetaminophen to children before vaccinations might reduce immunity
Pediatrics Intuniv (in-TOO-niv), a new extended-release guanfacine for ADHD
Cardiology whether proton pump inhibitors decrease the efficacy of clopidogrel (Plavix)
Women's Health whether ginger is safe during pregnancy
Women's Health how to switch women from oral to topical estrogens
Neurology & Pain whether it's okay for patients to take ketorolac (Toradol, etc) for more than 5 days
Neurology & Pain new IV version of ibuprofen, Caldolor
supplements for colds and flu
Gastroenterology rebound acid-related symptoms after stopping proton pump inhibitors (PPIs)